Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 588

1.

Editor's Note: mda-9/Syntenin: A Positive Regulator of Melanoma Metastasis.

Boukerche H, Su ZZ, Emdad L, Baril P, Balme B, Thomas L, Randolph A, Valerie K, Sarkar D, Fisher PB.

Cancer Res. 2019 Oct 1;79(19):5127. doi: 10.1158/0008-5472.CAN-19-2443. No abstract available.

PMID:
31575635
2.

Wnt7a and miR-370-3p: new contributors to bladder cancer invasion.

Scheunemann D, Pradhan AK, Das SK, Sarkar D, Emdad L, Fisher PB.

Biotarget. 2018 Sep;2. pii: 14. doi: 10.21037/biotarget.2018.08.02. Epub 2018 Sep 4. No abstract available.

3.

Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.

Jariwala N, Mendoza RG, Garcia D, Lai Z, Subler MA, Windle JJ, Mukhopadhyay ND, Fisher PB, Chen Y, Sarkar D.

Hepatol Commun. 2019 Jul 15;3(9):1258-1270. doi: 10.1002/hep4.1400. eCollection 2019 Sep.

4.

Mechanism of internalization of MDA-7/IL-24 protein and its cognate receptors following ligand-receptor docking.

Pradhan AK, Bhoopathi P, Talukdar S, Das SK, Emdad L, Sarkar D, Ivanov AI, Fisher PB.

Oncotarget. 2019 Aug 20;10(49):5103-5117. doi: 10.18632/oncotarget.27150. eCollection 2019 Aug 20.

5.

Regulation of neuroblastoma migration, invasion, and in vivo metastasis by genetic and pharmacological manipulation of MDA-9/Syntenin.

Bhoopathi P, Pradhan AK, Bacolod MD, Emdad L, Sarkar D, Das SK, Fisher PB.

Oncogene. 2019 Oct;38(41):6781-6793. doi: 10.1038/s41388-019-0920-5. Epub 2019 Aug 12.

PMID:
31406249
6.

Recent insights into apoptosis and toxic autophagy: The roles of MDA-7/IL-24, a multidimensional anti-cancer therapeutic.

Emdad L, Bhoopathi P, Talukdar S, Pradhan AK, Sarkar D, Wang XY, Das SK, Fisher PB.

Semin Cancer Biol. 2019 Jul 26. pii: S1044-579X(19)30023-9. doi: 10.1016/j.semcancer.2019.07.013. [Epub ahead of print] Review.

PMID:
31356866
7.

MDA-9/Syntenin: An emerging global molecular target regulating cancer invasion and metastasis.

Das SK, Sarkar D, Emdad L, Fisher PB.

Adv Cancer Res. 2019;144:137-191. doi: 10.1016/bs.acr.2019.03.011. Epub 2019 Apr 24.

PMID:
31349898
8.

Suppression of Prostate Cancer Pathogenesis Using an MDA-9/Syntenin (SDCBP) PDZ1 Small-Molecule Inhibitor.

Das SK, Kegelman TP, Pradhan AK, Shen XN, Bhoopathi P, Talukdar S, Maji S, Sarkar D, Emdad L, Fisher PB.

Mol Cancer Ther. 2019 Nov;18(11):1997-2007. doi: 10.1158/1535-7163.MCT-18-1019. Epub 2019 Jul 25.

PMID:
31345950
9.

Preface.

Wang XY, Fisher PB.

Adv Cancer Res. 2019;143:xiii-xv. doi: 10.1016/S0065-230X(19)30049-1. No abstract available.

PMID:
31202364
10.

Can CpG methylation serve as surrogate markers for immune infiltration in cancer?

Bacolod MD, Barany F, Fisher PB.

Adv Cancer Res. 2019;143:351-384. doi: 10.1016/bs.acr.2019.03.007. Epub 2019 Apr 17.

PMID:
31202362
11.

Immunometabolism: A new target for improving cancer immunotherapy.

Guo C, Chen S, Liu W, Ma Y, Li J, Fisher PB, Fang X, Wang XY.

Adv Cancer Res. 2019;143:195-253. doi: 10.1016/bs.acr.2019.03.004. Epub 2019 Apr 17.

PMID:
31202359
12.

Prevention of epithelial to mesenchymal transition in colorectal carcinoma by regulation of the E-cadherin-β-catenin-vinculin axis.

Pal I, Rajesh Y, Banik P, Dey G, Dey KK, Bharti R, Naskar D, Chakraborty S, Ghosh SK, Das SK, Emdad L, Kundu SC, Fisher PB, Mandal M.

Cancer Lett. 2019 Jun 28;452:254-263. doi: 10.1016/j.canlet.2019.03.008. Epub 2019 Mar 21.

PMID:
30904616
13.

Pathways- and epigenetic-based assessment of relative immune infiltration in various types of solid tumors.

Bacolod MD, Barany F, Pilones K, Fisher PB, de Castro RJ.

Adv Cancer Res. 2019;142:107-143. doi: 10.1016/bs.acr.2019.01.003. Epub 2019 Mar 6.

PMID:
30885360
14.

MDA-7/IL-24 regulates the miRNA processing enzyme DICER through downregulation of MITF.

Pradhan AK, Bhoopathi P, Talukdar S, Scheunemann D, Sarkar D, Cavenee WK, Das SK, Emdad L, Fisher PB.

Proc Natl Acad Sci U S A. 2019 Mar 19;116(12):5687-5692. doi: 10.1073/pnas.1819869116. Epub 2019 Mar 6.

15.

Preface.

Civin CI, Kingsbury TJ, Kim M, Fisher PB.

Adv Cancer Res. 2019;141:xi-xiii. doi: 10.1016/S0065-230X(19)30008-9. No abstract available.

PMID:
30691687
16.

Dormancy and cancer stem cells: An enigma for cancer therapeutic targeting.

Talukdar S, Bhoopathi P, Emdad L, Das S, Sarkar D, Fisher PB.

Adv Cancer Res. 2019;141:43-84. doi: 10.1016/bs.acr.2018.12.002. Epub 2019 Jan 16.

PMID:
30691685
17.

Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule.

Das SK, Sarkar D, Cavenee WK, Emdad L, Fisher PB.

ACS Chem Neurosci. 2019 Mar 20;10(3):1121-1123. doi: 10.1021/acschemneuro.9b00016. Epub 2019 Jan 25.

PMID:
30681320
18.

Astrocyte Elevated Gene-1 Regulates Macrophage Activation in Hepatocellular Carcinogenesis.

Robertson CL, Mendoza RG, Jariwala N, Dozmorov M, Mukhopadhyay ND, Subler MA, Windle JJ, Lai Z, Fisher PB, Ghosh S, Sarkar D.

Cancer Res. 2018 Nov 15;78(22):6436-6446. doi: 10.1158/0008-5472.CAN-18-0659. Epub 2018 Sep 4.

19.

Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin.

Talukdar S, Pradhan AK, Bhoopathi P, Shen XN, August LA, Windle JJ, Sarkar D, Furnari FB, Cavenee WK, Das SK, Emdad L, Fisher PB.

Autophagy. 2018;14(10):1845-1846. doi: 10.1080/15548627.2018.1502564. Epub 2018 Aug 17.

20.

Reply to Yoshida: Delineating critical roles of MDA-9 in protective autophagy-mediated anoikis resistance in human glioma stem cells.

Talukdar S, Das SK, Emdad L, Sarkar D, Cavenee WK, Fisher PB.

Proc Natl Acad Sci U S A. 2018 Aug 14;115(33):E7654-E7655. doi: 10.1073/pnas.1811113115. Epub 2018 Aug 7. No abstract available.

21.

Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway.

Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Emdad L, Das SK, Sarkar D, Fisher PB.

Mol Cancer Ther. 2018 Sep;17(9):1951-1960. doi: 10.1158/1535-7163.MCT-17-1002. Epub 2018 Jun 22.

22.

Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.

Kumar BNP, Puvvada N, Rajput S, Sarkar S, Mahto MK, Yallapu MM, Pathak A, Emdad L, Das SK, Reis RL, Kundu SC, Fisher PB, Mandal M.

Mol Pharm. 2018 Jul 2;15(7):2698-2713. doi: 10.1021/acs.molpharmaceut.8b00218. Epub 2018 May 30.

PMID:
29787277
23.

MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells.

Talukdar S, Pradhan AK, Bhoopathi P, Shen XN, August LA, Windle JJ, Sarkar D, Furnari FB, Cavenee WK, Das SK, Emdad L, Fisher PB.

Proc Natl Acad Sci U S A. 2018 May 29;115(22):5768-5773. doi: 10.1073/pnas.1721650115. Epub 2018 May 14.

24.

Multi-nucleated cells use ROS to induce breast cancer chemo-resistance in vitro and in vivo.

Parekh A, Das S, Parida S, Das CK, Dutta D, Mallick SK, Wu PH, Kumar BNP, Bharti R, Dey G, Banerjee K, Rajput S, Bharadwaj D, Pal I, Dey KK, Rajesh Y, Jena BC, Biswas A, Banik P, Pradhan AK, Das SK, Das AK, Dhara S, Fisher PB, Wirtz D, Mills GB, Mandal M.

Oncogene. 2018 Aug;37(33):4546-4561. doi: 10.1038/s41388-018-0272-6. Epub 2018 May 10.

PMID:
29743594
25.

Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.

Leem E, Kim HJ, Choi M, Kim S, Oh YS, Lee KJ, Choe YS, Um JY, Shin WH, Jeong JY, Jin BK, Kim DW, McLean C, Fisher PB, Kholodilov N, Ahn KS, Lee JM, Jung UJ, Lee SG, Kim SR.

Cell Death Dis. 2018 May 1;9(5):449. doi: 10.1038/s41419-018-0491-3.

26.

The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion.

Das SK, Pradhan AK, Bhoopathi P, Talukdar S, Shen XN, Sarkar D, Emdad L, Fisher PB.

Cancer Res. 2018 Jun 1;78(11):2852-2863. doi: 10.1158/0008-5472.CAN-17-2992. Epub 2018 Mar 23.

27.

Prospects of Gene Therapy to Treat Melanoma.

Menezes ME, Talukdar S, Wechman SL, Das SK, Emdad L, Sarkar D, Fisher PB.

Adv Cancer Res. 2018;138:213-237. doi: 10.1016/bs.acr.2018.02.007. Review.

PMID:
29551128
28.

Role of MDA-7/IL-24 a Multifunction Protein in Human Diseases.

Menezes ME, Bhoopathi P, Pradhan AK, Emdad L, Das SK, Guo C, Wang XY, Sarkar D, Fisher PB.

Adv Cancer Res. 2018;138:143-182. doi: 10.1016/bs.acr.2018.02.005. Epub 2018 Mar 2. Review.

29.

New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity.

Wechman SL, Pradhan AK, DeSalle R, Das SK, Emdad L, Sarkar D, Fisher PB.

Adv Cancer Res. 2018;137:77-114. doi: 10.1016/bs.acr.2017.11.002. Epub 2017 Dec 27. Review.

PMID:
29405978
30.

Bcl-2 Antiapoptotic Family Proteins and Chemoresistance in Cancer.

Maji S, Panda S, Samal SK, Shriwas O, Rath R, Pellecchia M, Emdad L, Das SK, Fisher PB, Dash R.

Adv Cancer Res. 2018;137:37-75. doi: 10.1016/bs.acr.2017.11.001. Epub 2017 Dec 6. Review.

PMID:
29405977
31.

Cancer terminator viruses (CTV): A better solution for viral-based therapy of cancer.

Emdad L, Das SK, Wang XY, Sarkar D, Fisher PB.

J Cell Physiol. 2018 Aug;233(8):5684-5695. doi: 10.1002/jcp.26421. Epub 2018 Feb 27. Review.

32.

Preface.

Croce CM, Fisher PB.

Adv Cancer Res. 2017;135:ix-xi. doi: 10.1016/S0065-230X(17)30034-9. No abstract available.

PMID:
28882226
33.

The Enigma of miRNA Regulation in Cancer.

Pradhan AK, Emdad L, Das SK, Sarkar D, Fisher PB.

Adv Cancer Res. 2017;135:25-52. doi: 10.1016/bs.acr.2017.06.001. Epub 2017 Aug 7. Review.

PMID:
28882224
34.

Micellear Gold Nanoparticles as Delivery Vehicles for Dual Tyrosine Kinase Inhibitor ZD6474 for Metastatic Breast Cancer Treatment.

Sarkar S, Konar S, Prasad PN, Rajput S, Kumar BNP, Rao RR, Pathak A, Fisher PB, Mandal M.

Langmuir. 2017 Aug 8;33(31):7649-7659. doi: 10.1021/acs.langmuir.7b01072. Epub 2017 Jul 28.

PMID:
28701038
35.

IGFBP7 Deletion Promotes Hepatocellular Carcinoma.

Akiel M, Guo C, Li X, Rajasekaran D, Mendoza RG, Robertson CL, Jariwala N, Yuan F, Subler MA, Windle J, Garcia DK, Lai Z, Chen HH, Chen Y, Giashuddin S, Fisher PB, Wang XY, Sarkar D.

Cancer Res. 2017 Aug 1;77(15):4014-4025. doi: 10.1158/0008-5472.CAN-16-2885. Epub 2017 Jun 15.

36.

A novel role of astrocyte elevated gene-1 (AEG-1) in regulating nonalcoholic steatohepatitis (NASH).

Srivastava J, Robertson CL, Ebeid K, Dozmorov M, Rajasekaran D, Mendoza R, Siddiq A, Akiel MA, Jariwala N, Shen XN, Windle JJ, Subler MA, Mukhopadhyay ND, Giashuddin S, Ghosh S, Lai Z, Chen Y, Fisher PB, Salem AK, Sanyal AJ, Sarkar D.

Hepatology. 2017 Aug;66(2):466-480. doi: 10.1002/hep.29230. Epub 2017 Jun 30.

37.

Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.

Jariwala N, Rajasekaran D, Mendoza RG, Shen XN, Siddiq A, Akiel MA, Robertson CL, Subler MA, Windle JJ, Fisher PB, Sanyal AJ, Sarkar D.

Cancer Res. 2017 Jun 15;77(12):3306-3316. doi: 10.1158/0008-5472.CAN-17-0298. Epub 2017 Apr 20.

38.

The American Society for Clinical Pathology's 2015 Wage Survey of Medical Laboratories in the United States.

Garcia E, Fisher PB.

Lab Med. 2017 May 1;48(2):113-136. doi: 10.1093/labmed/lmx031.

PMID:
28419268
39.

The American Society for Clinical Pathology's 2015 Wage Survey of Medical Laboratories in the United States.

Garcia E, Fisher PB.

Am J Clin Pathol. 2017 Apr 1;147(4):334-356. doi: 10.1093/ajcp/aqw220.

PMID:
28339797
40.

HIV induces expression of complement component C3 in astrocytes by NF-κB-dependent activation of interleukin-6 synthesis.

Nitkiewicz J, Borjabad A, Morgello S, Murray J, Chao W, Emdad L, Fisher PB, Potash MJ, Volsky DJ.

J Neuroinflammation. 2017 Jan 26;14(1):23. doi: 10.1186/s12974-017-0794-9.

41.

Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy.

Bharti R, Dey G, Banerjee I, Dey KK, Parida S, Kumar BN, Das CK, Pal I, Mukherjee M, Misra M, Pradhan AK, Emdad L, Das SK, Fisher PB, Mandal M.

Cancer Lett. 2017 Mar 1;388:292-302. doi: 10.1016/j.canlet.2016.12.021. Epub 2016 Dec 24.

PMID:
28025102
42.

Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin.

Kegelman TP, Wu B, Das SK, Talukdar S, Beckta JM, Hu B, Emdad L, Valerie K, Sarkar D, Furnari FB, Cavenee WK, Wei J, Purves A, De SK, Pellecchia M, Fisher PB.

Proc Natl Acad Sci U S A. 2017 Jan 10;114(2):370-375. doi: 10.1073/pnas.1616100114. Epub 2016 Dec 23.

43.

mda-7/IL-24 Mediates Cancer Cell-Specific Death via Regulation of miR-221 and the Beclin-1 Axis.

Pradhan AK, Talukdar S, Bhoopathi P, Shen XN, Emdad L, Das SK, Sarkar D, Fisher PB.

Cancer Res. 2017 Feb 15;77(4):949-959. doi: 10.1158/0008-5472.CAN-16-1731. Epub 2016 Dec 9.

44.

Astrocyte Elevated Gene-1 Regulates β-Catenin Signaling to Maintain Glioma Stem-like Stemness and Self-Renewal.

Hu B, Emdad L, Kegelman TP, Shen XN, Das SK, Sarkar D, Fisher PB.

Mol Cancer Res. 2017 Feb;15(2):225-233. doi: 10.1158/1541-7786.MCR-16-0239. Epub 2016 Nov 30.

45.

MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer.

Menezes ME, Shen XN, Das SK, Emdad L, Sarkar D, Fisher PB.

Oncotarget. 2016 Dec 6;7(49):80175-80189. doi: 10.18632/oncotarget.13373.

46.

AEG-1 promotes mesenchymal transition through the activation of Rho GTPases in human glioblastoma cells.

Park SY, Choi M, Park D, Jeong M, Ahn KS, Lee J, Fisher PB, Yun M, Lee SG.

Oncol Rep. 2016 Nov;36(5):2641-2646. doi: 10.3892/or.2016.5106. Epub 2016 Sep 19.

PMID:
27667169
47.

Immune infiltration, glioma stratification, and therapeutic implications.

Bacolod MD, Talukdar S, Emdad L, Das SK, Sarkar D, Wang XY, Barany F, Fisher PB.

Transl Cancer Res. 2016 Oct;5(Suppl 4):S652-S656. doi: 10.21037/tcr.2016.10.69. No abstract available.

48.

Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling.

Zhang G, Park MA, Mitchell C, Walker T, Hamed H, Studer E, Graf M, Rahmani M, Gupta S, Hylemon PB, Fisher PB, Grant S, Dent P.

J Biol Chem. 2016 Sep 23;291(39):20823. doi: 10.1074/jbc.A116.803444. No abstract available.

49.

Preface.

Welch DR, Fisher PB.

Adv Cancer Res. 2016;132:xi-xiv. doi: 10.1016/S0065-230X(16)30064-1. No abstract available.

PMID:
27613136
50.

Detecting Tumor Metastases: The Road to Therapy Starts Here.

Menezes ME, Das SK, Minn I, Emdad L, Wang XY, Sarkar D, Pomper MG, Fisher PB.

Adv Cancer Res. 2016;132:1-44. doi: 10.1016/bs.acr.2016.07.001. Epub 2016 Aug 17. Review.

Supplemental Content

Loading ...
Support Center